FDA product code QFG: Alternate Controller Enabled Insulin Infusion Pump
QFG is the FDA product code for alternate controller enabled insulin infusion pump. It is a Class II device, regulated under 21 CFR 880.5730 and reviewed by the Clinical Chemistry panel. FDA has cleared 29 510(k) submissions under QFG, 27 in the last five years, from 9 different applicants. The average 510(k) review took 165 days (median 97); 94 days on average over the last three years. 1 De Novo request was granted under it. FDA has posted 24 recalls for QFG devices, 24 initiated in the last five years.
Definition
An alternate controller enabled insulin infusion pump (ACE insulin pump) is a device intended for the infusion of insulin into a patient. The ACE insulin pump may include basal and bolus drug delivery at set or variable rates. ACE insulin pumps are designed to reliably and securely communicate with external devices, such as automated insulin dosing systems, to allow insulin delivery commands to be received, executed, and confirmed. ACE insulin pumps are intended to be used both alone and in conjunction with digitally connected medical devices for the purpose of insulin delivery.
Classification
| Field | Value |
|---|---|
| Device name | Alternate Controller Enabled Insulin Infusion Pump |
| Device class | Class II |
| Regulation | 21 CFR 880.5730 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | Clinical Chemistry |
| Premarket route | 510(k) |
510(k) clearances per year for QFG
| Year | Clearances | Avg. review days |
|---|---|---|
| 2019 | 1 | 88 |
| 2020 | 1 | 30 |
| 2022 | 2 | 434 |
| 2023 | 9 | 252 |
| 2024 | 5 | 103 |
| 2025 | 5 | 72 |
| 2026 | 6 | 108 |
Compare with all 510(k) review times · Search every QFG clearance
Top QFG applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Tandem Diabetes Care, Inc. | 9 | 2025-11-06 |
| Beta Bionics, Inc. | 6 | 2026-10-21 |
| Deka Research and Development | 4 | 2026-06-17 |
| Medtronic Minimed, Inc. | 3 | 2026-03-12 |
| Insulet Corporation | 3 | 2023-10-18 |
4 more applicants have QFG clearances. See the full list in Caduvo.
Most recent QFG clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K263422 | Beta Bionics, Inc. | Mint ACE Pump | 2026-10-21 | 26 |
| K260001 | Beta Bionics, Inc. | Mint ACE Pump | 2026-09-11 | 252 |
| K261672 | Deka Research and Development | twiist Automated Insulin Delivery (AID) System | 2026-06-17 | 27 |
| K253976 | Beta Bionics, Inc. | iLet ACE Pump | 2026-04-30 | 139 |
| K253743 | Medtronic Minimed, Inc. | MiniMed Flex pump | 2026-03-12 | 108 |
Recalls for QFG devices
24 product recalls in 22 recall events; 24 initiated in the last five years and 24 still open. Most recent: 2026-09-23.
| Year | Recalls |
|---|---|
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 8 |
| 2026 | 12 |
HCPCS codes with matching descriptors
Text match between the FDA device name and CMS descriptors, not an official crosswalk:
- A4220 — Refill kit for implantable infusion pump
Frequently asked questions
What is FDA product code QFG?
QFG is the FDA product code for alternate controller enabled insulin infusion pump. It is a Class II device, regulated under 21 CFR 880.5730 and reviewed by the Clinical Chemistry panel.
What device class is QFG?
Class II, regulation 21 CFR 880.5730. Typical premarket route: 510(k).
How long does a 510(k) take for product code QFG?
Across 29 cleared submissions the average was 165 days from receipt to decision (median 97).
Which companies have the most QFG clearances?
Tandem Diabetes Care, Inc. (9); Beta Bionics, Inc. (6); Deka Research and Development (4); Medtronic Minimed, Inc. (3); Insulet Corporation (3).
Have QFG devices been recalled?
Yes: 24 product recalls across 22 recall events; the most recent began 2026-09-23.
Next steps
- Run an FDA pathway report with predicate devices for product code QFG
- Run a recall and safety report across every QFG manufacturer
- Watch product code QFG for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times